Showing results (101-110 of 173) with videos related to
Sort By:
Pageof 18
Life Science Alliance|January 15, 2025
UNC119 regulates T-cell receptor signalling in primary T cells and T acute lymphocytic leukaemiaYouhani Samarakoon, Tamas Yelland, Esther Garcia-Gonzalez, et al.Pediatric Blood & Cancer|June 1, 2026
Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic LeukemiaLaura Almási, Bernadett Borbála Huszti, Gábor Barna, et al.The Lancet. Haematology|December 4, 2018
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trialAndrea Biondi, Virginie Gandemer, Paola De Lorenzo, et al.Haematologica|October 7, 2017
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphomaEva Landmann, Birgit Burkhardt, Martin Zimmermann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of GeneticsCornelia Eckert, Stefanie Groeneveld-Krentz, Renate Kirschner-Schwabe, et al.Leukemia & Lymphoma|May 3, 2018
Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapyKathinka Krull, Marina Kunstreich, Annika Bronsema, et al.Blood|July 18, 2024
Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcomeMarcel Te Vrugt, Janna Wessolowski, Gerrit Randau, et al.BMC Pediatrics|February 2, 2020
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational studyJulia Roick, Reinhard Berner, Toralf Bernig, et al.Journal of Hematology & Oncology|January 17, 2025
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adultsMaike Breidenbach, Peter Bader, Andishe Attarbaschi, et al.Blood|September 26, 2014
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibitionJulie Irving, Elizabeth Matheson, Lynne Minto, et al.Pageof 18